ey0017.5-7 | Translational Highlights | ESPEYB17
B Palmisano
, E Spica
, C Remoli
, R Labella
, A Di Filippo
, S Donsante
, F Bini
, D Raimondo
, F Marinozzi
, A Boyde
, P Robey
, A Corsi
, M Riminucci
To read the full abstract: J Bone Miner Res. 2019;34(12):21712182.In brief: The effect of RANKL inhibition on fibrous dysplasia development is explored here using a mouse model of a fibrous dysplasia-like disorder. Anti-mouse RANKL monoclonal antibody treatment prevented the development and growth of lesions. However, after discontinuation of anti-mouse ...